Reimbursement [Neurosurgery Wiki]

This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong.
====== Reimbursement ======

Reimbursement is an act of compensating someone for an expense.

Often, a person is reimbursed for out-of-pocket expenses when the person incurs those expenses through employment or in an account of carrying out the duties for another party or member.

Common examples are firms compensating individuals who buy supplies for their companies, or firms compensating employees on field or out-of-town assignments who pay for their stay and transportation.

Reimbursement can be of many types like day care, mobile expenses, transport, medical expenses, and study expenditure.
----
A [[Diagnosis-Related Group]] (DRG) is a system used in [[healthcare]] to classify and group [[patient]]s with similar clinical [[condition]]s and [[resource]] utilization. DRGs are primarily utilized for billing and [[reimbursement]] in healthcare settings.
----


see [[Hospital reimbursement]].

[[Medicare Reimbursement]]

see [[Physician reimbursement]].



Medical device manufacturers provide their customers (hospitals, physicians e.g.) with sufficient information, how to reimburse the therapies. For example see the German Medtronic Reimbursement homepage

http://www.medtronic.de/fachkreise/reimbursement/index.htm

[[Value base purchasing]] and pay-for-performance models are driving the development of [[bundled payment]] systems for reimbursement. To build a sustainable bundling system, it is important to identify the contributions of each component of index surgery total cost and determine the domain where targeted savings can occur.
----
The [[quality]] of [[clinical research]] in surgery has long attracted criticism. High-quality randomised trials have proved difficult to undertake in surgery, and many [[surgical treatment]]s have therefore been adopted without adequate supporting evidence of [[efficacy]] and [[safety]]. This evidence deficit can adversely affect research funding and [[reimbursement]] decisions, lead to slow adoption of [[innovation]]s, and permit widespread adoption of procedures that offer no benefit, or cause harm.